ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1113

Intrameniscal Signal Alterations Strongly Predict Destabilizing Meniscal Tears and Accelerated Knee Osteoarthritis: Data from the Osteoarthritis Initiative

Jeffrey Driban1, James MacKay2, Timothy McAlindon1, Matthew Harkey3, Bing Lu4, Charles Eaton5, Grace Lo6, Mary Barbe7 and Robert Ward1, 1Tufts Medical Center, Boston, MA, 2University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital; Norwich Medical School, University of East Anglia, Cambridge, United Kingdom, 3University of Massachusetts, Worcester, MA, 4Brigham and Women's Hospital and Harvard Medical School, Newton, MA, 5Brown University, Pawtucket, RI, 6Michael E. Debakey VA Medical Center, Baylor College of Medicine, Houston, TX, 7Temple University School of Medicine, Philadelphia, PA

Meeting: ACR Convergence 2020

Keywords: Joint Structure, Magnetic resonance imaging (MRI), Osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: It is unknown whether early changes in the menisci (e.g., intrameniscal signal alterations) have long-term consequences. We conducted a study to assess the prognostic potential of intrameniscal signal alterations with incident destabilizing meniscal tears (radial or complex tears or macerated menisci) or accelerated knee osteoarthritis (KOA).

Methods: We used existing magnetic resonance (MR)-based data from a sex-matched nested case-control study of 3 groups from the Osteoarthritis Initiative without radiographic KOA at baseline (Kellgren-Lawrence [KL] < 2): 1) accelerated KOA: developed KL 3 or 4 within 48 months; 2) typical KOA: increased in KL grade within 48 months (excluding accelerated KOA); 3) no KOA: no change in KL grade within 48 months. From the original groups (n = 375), we included people with intact medial and lateral menisci at baseline (n = 226) and 48-month meniscal data (n = 221). Two readers read annual intermediate-weighted MR sequences with and without fat-suppression from baseline to the 48-month visit using a modified version of the International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine meniscal tear classification. The readers assessed 3 regions (anterior, body, posterior) of the medial and lateral menisci. Baseline meniscal status was operationally defined: 1) normal (intact with no signal intensity abnormalities) and 2) intrameniscal signal alteration (intrameniscal increased signal on a fluid-sensitive sequence that does not extend to an articular surface). We defined an incident destabilizing meniscal tear as the emergence of a radial (including root tears) or complex tear or maceration. Our readers had good inter-reader agreement (medial meniscal interobserver kappa = 0.90; lateral meniscal kappa = 0.63). We used 2 logistic regression models to assess 1) whether the presence of medial intrameniscal signal alteration (predictor) was associated with an incident medial destabilizing meniscal tear versus no incident medial destabilizing meniscal tear (reference group), and 2) if the presence of intrameniscal alterations in either meniscus predicted incident accelerated versus typical KOA (reference group) over the next 4 years.

Results: We analyzed 221 knees with intact medial and lateral menisci at baseline. Overall, the study sample was mostly female (68%), with an average age of 58 (8) years, and an average body mass index of 28.1 (4.8) kg/m2. The presence of medial intrameniscal signal alterations was strongly associated with incident medial destabilizing meniscal tears (odds ratio = 3.0 [95% CI = 1.4 to 6.6]; Table). Though numbers were small, 8 out of 9 incident lateral destabilizing meniscal tears had lateral intrameniscal signal alterations at baseline. The presence of baseline intrameniscal signal alteration in a knee strongly predicted the onset of accelerated versus typical KOA (odds ratio = 3.7 [95% CI = 1.7 to 8.0]; Table).

Conclusion: Intrameniscal signal alterations on intermediate-weighted fat-suppressed images may be clinically meaningful as they relate to future outcomes. Intrameniscal signal alterations may be a potential therapeutic target and warrant further study.


Disclosure: J. Driban, Pfizer, Inc., 1, 2, Eli Lilly and Company, 1; J. MacKay, None; T. McAlindon, Pfizer, 1, Sanofi Aventis US, 1, Kolon Tissuegene, 1, Samumed, 1, Seikagaku, 1, Kiniksa Pharmaceuticals, 1, Anika Therapeutics, 1; M. Harkey, Pfizer, Inc., 1; B. Lu, None; C. Eaton, None; G. Lo, Takeda Pharmaceuticals, 1, Taro Pharmaceuticals, 1, Teva Pharmaceuticals, 1, XBI Biotech Co, 1; M. Barbe, None; R. Ward, None.

To cite this abstract in AMA style:

Driban J, MacKay J, McAlindon T, Harkey M, Lu B, Eaton C, Lo G, Barbe M, Ward R. Intrameniscal Signal Alterations Strongly Predict Destabilizing Meniscal Tears and Accelerated Knee Osteoarthritis: Data from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/intrameniscal-signal-alterations-strongly-predict-destabilizing-meniscal-tears-and-accelerated-knee-osteoarthritis-data-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/intrameniscal-signal-alterations-strongly-predict-destabilizing-meniscal-tears-and-accelerated-knee-osteoarthritis-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology